Loading…
avatar for Christopher Downey

Christopher Downey

FDA
Review Chief, OBP, OPQ, CDER
Christopher (Chris) Downey is a Review Chief in FDA/CDER’s Office of Biotechnology Products (OBP). He was been with FDA since 2012, and currently oversees CMC reviews of therapeutic proteins, including new molecular entities and biosimilars. He received his PhD in Biochemistry from the University of Colorado at Boulder and did postdoctoral research at the University of Colorado and Georgetown University Medical Center.

My Speakers Sessions

Tuesday, June 26
 

10:30am